calendar
30,457 catalysts · 10,858 approval · 5,000 device 510k · 4,728 grant · 3,080 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
30,457 catalysts · 10,858 approval · 5,000 device 510k · 4,728 grant · 3,080 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: RILEY CONSUMER. Form: CAPSULE. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: CUMBERLAND PHARMS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: COLLEGIUM PHARM INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL
Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE
Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL
Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: AVION PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AYTU. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL
Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: IMPAX. Form: INJECTABLE. Route: INTRAMUSCULAR, SUBCUTANEOUS
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: CEPHALON. Form: TABLET. Route: BUCCAL, SUBLINGUAL
Sponsor: BIOVITRUM AB. Form: VIAL. Route: SUBCUTANEOUS